Camrelizumab Plus R-CHOP Regimen in Untreated Primary Extranodal DLBCL
Clinical trial NCT05093140 · UNKNOWN
Trial details
- NCT number
- NCT05093140
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2023-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.